CGTX Latest Quarter’s Earnings
Announce Date11/5/2026
EPS Actual (USD)-0.04
Revenue Actual (USD)--
Cognition Therapeutics Inc Earnings Dates & Reports
This page offers detailed Cognition Therapeutics Inc earnings data including the latest Cognition Therapeutics Inc earnings report, the upcoming Cognition Therapeutics Inc earnings date, historical data and Cognition Therapeutics Inc earnings call news.
CGTX Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
CGTX FY2025 Earnings
EPS (YoY)-0.3262.25%
Revenue (YoY)----
Cognition Therapeutics Inc (CGTX) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/5/2026 | 09/2026 | -0.04/-0.07 | --/0.00 | 40.00% | -- |
| 8/7/2026 | 06/2026 | -0.04/-0.06 | --/0.00 | 31.49% | -- |
| 5/7/2026 | 03/2026 | -0.05/-0.07 | --/0.00 | 24.09% | -- |
| 3/26/2026 | 12/2025 | -0.04/-0.08 | --/0.00 | 54.72% | -- |
| 11/6/2025 | 09/2025 | -0.06/-0.10 | --/0.00 | 36.76% | -- |
| 8/7/2025 | 06/2025 | -0.11/-0.11 | --/0.00 | 0.88% | -- |
| 5/7/2025 | 03/2025 | -0.14/-0.11 | --/0.00 | -24.40% | -- |
| 3/20/2025 | 12/2024 | -0.18/-0.14 | --/0.00 | -23.61% | -- |
Cognition Therapeutics Inc Latest Earnings Call Transcripts
Cognition Therapeutics (CGTX) Q3 2026 Earnings Call: DLB Phase III Plan Advances
Cognition Therapeutics’ Q3 2026 earnings call detailed its FDA-aligned zervimesine DLB Phase III plan, $31.5 million cash balance and 2027 milestones.